WHO media sanctions have little effect

Apparently, the punishment the World Health Organization (WHO) meted out to the New York Times for linkurl:breaking an embargo last week;http://www.the-scientist.com/blog/display/53943/ didn't deter other media outlets from doing the same yesterday and today. Early this morning -- 4:28 EST, to be precise -- the WHO sent out a notice to its media list saying that an embargo on a story about children's medicines was being lifted immediately because it had been broken. I searched Google News for

Written byIvan Oransky
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share
Apparently, the punishment the World Health Organization (WHO) meted out to the New York Times for linkurl:breaking an embargo last week;http://www.the-scientist.com/blog/display/53943/ didn't deter other media outlets from doing the same yesterday and today. Early this morning -- 4:28 EST, to be precise -- the WHO sent out a notice to its media list saying that an embargo on a story about children's medicines was being lifted immediately because it had been broken. I searched Google News for stories based on the press release, and found two news organizations that seem to have broken the embargo, if the Google News and the sites' own time stamps are correct: The linkurl:Matangi Tonga;http://www.matangitonga.to/article/children_061207_0531_pf.shtml and the linkurl:Voice of America. ;http://www.voanews.com/english/2007-12-05-voa34.cfm The Tonga story is time-stamped 05:31, and Tonga is 13 hours ahead of GMT, so it was posted sometime yesterday GMT time. If you're confused, I can't quite figure out when either, but it was clearly before today's 12:30 GMT embargo. The VOA story was also posted sometime yesterday. "WHO is investigating the circumstances surrounding the breach," according to the organization's note. Maybe this is the beginning of a movement of a bunch of people who hate embargoes as much as I do, but have more courage. But I doubt it -- that would require not agreeing to embargoes in the first place.
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies